Pfizer's (PFE.US) $43 billion Seagen (SGEN.US) deal wins unconditional EU approval. As it was concluded by European lawmakers, deal wouldn't raise competition concerns or higher prices for oncology drugs.
Source: xStation5
Morning Wrap: A New Threat of Conflict in the Middle East 🚨 (23.07.2026)
Alphabet and Tesla report earnings 🚩 Google's AI business shines, Tesla accelerates Optimus plans
Daily Summary: Wall Street Stabilizes Despite Higher Oil Prices
All or nothing: ServiceNow earnings preview